IP Library Granted Patent US 11,261,154
Granted Patent B2
US 11,261,154 · App. 17/264,603 · Granted Mar 1, 2022

Benzene derivative

Inventors: Shoji Nojima (Osaka, JP); Kenji Sasaki (Osaka, JP); Tohru Kambe (Osaka, JP); Takashi Konemura (Osaka, JP); Yoshikazu Goto (Osaka, JP)
Assignee: ONO PHARMACEUTICAL CO., LTD.
C07C311/21
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,261,154
App. No.
17/264,603
Granted
Mar 1, 2022
Kind
B2
Abstract

A compound represented by general formula (I) (in the formula, all symbols are as described in the description) or a salt thereof has a potent nerve-protecting and/or -repairing activity, and therefore can be used as a therapeutic agent for neuropathy (e.g., chronic inflammatory demyelinating polyneuropathy, Guillain-Barre syndrome, periarteritis nodosa, allergic vasculitis, diabetic peripheral neuropathy, entrapment neuropathy, peripheral neuropathy associated with the administration of a chemotherapeutic drug, or peripheral neuropathy associated with Charcot-Marie-Tooth disease).

Claims (3)

1. 3-[2-[(E)-5-[3-(benzenesulfonamide)phenyl]pent-4-enoxy]phenyl]propanoic acid, or a salt thereof.

2. A compund having the following structural formula:

3. A salt of compound having the following structural formula:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2021
From: NOJIMA, SHOJI; SASAKI, KENJI; KAMBE, TOHRU; KONEMURA, TAKASHI; GOTO, YOSHIKAZU
To: ONO PHARMACEUTICAL CO., LTD.
Reel/Frame 055082/0197 →
Priority Claims (1)
JP JP2018-143024 · Jul 31, 2018 · national
Continuity (1)
Related Publication 20210332009A1 · Oct 28, 2021
Cited By (1)
US 12,258,308